Associating bovine herpesvirus 1 envelope glycoprotein gD with activated phospho-PLC-γ1(S1248).
Golgi apparatus
bovine herpesvirus 1
gD
phospholipase C-γ1
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
01 Sep 2023
01 Sep 2023
Historique:
medline:
1
9
2023
pubmed:
1
9
2023
entrez:
1
9
2023
Statut:
aheadofprint
Résumé
Phospholipase C gamma 1 (PLC-γ1) may locate at distinct subcellular locations, such as cytosol, plasma membrane, and nucleus for varied biological functions. Bovine herpesvirus 1 (BoHV-1) productive infection activates PLC-γ1 signaling, as demonstrated by increased protein levels of phosphorylated-PLC-γ1 at Ser1248 [p-PLC-γ1(S1248)], which benefits virus productive infection. Here, for the first time, we reported that Golgi apparatus also contains activated p-PLC-γ1(S1248). And BoHV-1 productive infection at later stages (24 hpi) increased the accumulation of p-PLC-γ1(S1248) in the Golgi apparatus, where p-PLC-γ1(S1248) forms highlighted puncta observed via a confocal microscope. Coimmunoprecipitation studies demonstrated that the Golgi p-PLC-γ1(S1248) is specifically associated with the viral protein gD but not gC. In addition, we found that p-PLC-γ1(S1248) is consistently associated with both the plasma membrane-associated virions and the released virions. When the virus-infected cells were treated with PLC-γ1-specific inhibitor, U73122, for a short duration of 4 hours prior to the endpoint of virus infection, we found that the viral protein gD was trapped in the Golgi apparatus, suggesting that the PLC-γ1 signaling may facilitate trafficking of progeny virions out of this organelle. These findings provide a novel insight into the interplay between PLC-γ1 signaling and BoHV-1 replication. IMPORTANCE Bovine herpesvirus 1 (BoHV-1) productive infection increases protein levels of phosphorylated-phospholipase C gamma 1 at Ser1248 [p-PLC-γ1(S1248)]. However, whether it causes any variations to p-PLC-γ1(S1248) localization is not well understood. Here, for the first time, we found that partial p-PLC-γ1(S1248) is residing in the Golgi apparatus, where the accumulation is enhanced by virus infection. p-PLC-γ1(S1248) is consistently associated with virions, partially via binding to gD, in both the Golgi apparatus and cytoplasm membranes. Surprisingly, it also associates with the released virions. Of note, this is the first evidenced BoHV-1 virion-bound host protein. It seems that p-PLC-γ1(S1248) works as an escort during trafficking of progeny virions out of Golgi apparatus to the plasma membranes as well as releasing outside of the cell membranes. Furthermore, we showed that the activated p-PLC-γ1(S1248) is potentially implicated in the transport of virions out of Golgi apparatus, which may represent a novel mechanism to regulate virus productive infection.
Identifiants
pubmed: 37655900
doi: 10.1128/spectrum.01963-23
pmc: PMC10580943
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0196323Références
Anim Health Res Rev. 2007 Dec;8(2):187-205
pubmed: 18218160
Viruses. 2022 Sep 08;14(9):
pubmed: 36146791
Cells. 2022 Jul 23;11(15):
pubmed: 35892570
Viruses. 2020 Aug 24;12(9):
pubmed: 32846937
Adv Virus Res. 1995;45:191-223
pubmed: 7793325
Mol Biol Cell. 2006 May;17(5):2267-77
pubmed: 16525023
Am J Physiol Cell Physiol. 2007 May;292(5):C1775-86
pubmed: 17229814
J Biol Chem. 2010 Nov 12;285(46):35836-47
pubmed: 20807769
Cell. 1991 May 3;65(3):435-41
pubmed: 1708307
Front Immunol. 2019 May 07;10:1008
pubmed: 31134079
J Cell Biol. 2001 Apr 30;153(3):599-612
pubmed: 11331309
Vet Microbiol. 2017 Jul;206:69-77
pubmed: 28377131
J Virol. 2018 Nov 12;92(23):
pubmed: 30232182
J Cell Sci. 2012 Jul 1;125(Pt 13):3153-63
pubmed: 22454520
Virology. 2016 Sep;496:131-137
pubmed: 27310357
Acta Virol. 2017;61(4):483-486
pubmed: 29186966
Comp Funct Genomics. 2005;6(4):244-50
pubmed: 18629190
J Gen Virol. 2010 Sep;91(Pt 9):2145-51
pubmed: 20505007
Traffic. 2009 Aug;10(8):1074-83
pubmed: 19548982
J Virol. 1999 Nov;73(11):9515-20
pubmed: 10516060
Vet Res. 2007 Mar-Apr;38(2):181-209
pubmed: 17257569
Exp Mol Med. 2000 Sep 30;32(3):101-9
pubmed: 11048639
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):559-63
pubmed: 8290562
Vet Res. 2017 Sep 7;48(1):45
pubmed: 28882164
Mol Cell Biol. 2001 Oct;21(20):6939-50
pubmed: 11564877
J Virol Methods. 1998 Feb;70(2):219-24
pubmed: 9562416
Vet Clin North Am Food Anim Pract. 1997 Nov;13(3):367-77
pubmed: 9368983
Nat Rev Microbiol. 2011 May;9(5):382-94
pubmed: 21494278
Animals (Basel). 2020 May 28;10(6):
pubmed: 32481546
J Immunol Res. 2018 Feb 8;2018:5201759
pubmed: 30057916
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):906-11
pubmed: 20080774
Immunity. 1998 Aug;9(2):239-46
pubmed: 9729044
J Virol. 2014 Jan;88(1):417-24
pubmed: 24155396
Int Immunopharmacol. 2015 Dec;29(2):622-627
pubmed: 26428848
Biochemistry. 1989 Jul 11;28(14):6010-6
pubmed: 2550068
J Virol. 2019 Mar 5;93(6):
pubmed: 30626671
J Biol Chem. 2007 Mar 23;282(12):8695-703
pubmed: 17242406
Vaccine. 2016 Jun 24;34(30):3478-92
pubmed: 27108192